Clinical Trials · NCT01638260
GLP-1 and Non-exercise Activity Thermogenesis in RHZ
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- Maastricht University Medical Center
- Enrollment
- 22
- Start date
- Oct 2012
- Locations
- 1 site, Netherlands
- Primary endpoint
- Change in HbA1c from baseline and end of treatment (26 weeks) and end of follow-up (52 weeks)